Live Breaking News & Updates on Vistagen Therapeutics Inc|Page 4
Stay updated with breaking news from Vistagen therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stifel Nicolaus initiated coverage on shares of Vistagen Therapeutics (NASDAQ:VTGN – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. The firm issued a buy rating and a $12.00 price target on the stock. Separately, Maxim Group reiterated a buy rating and issued a $30.00 price target on shares of Vistagen […] ....
TODAY’S GAME PLAN: from the trading desk, this is not research DATA/HEADLINES 8:30ET CPI, Fed’s Barkin speaks; 10:00ET Fed’s Barr speaks; 12:45ET Fed’s Goolsbee speaks TODAY’S HIGHLIGHTS: Israeli military says it found signs hostages were held in Gaza hospital The Supreme Court is getting an ethics codeNasdaq's "green Mondays" winning streak ends after 19 straight ....